Cargando…
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Epithelial ovarian cancer (EOC) is usually diagnosed late at an advanced stage. Though EOC initially responds to treatment, the recurrence rate is pretty high. The efficacy of different targeted therapies reduces with each recurrence. Hence there is need of effective maintenance therapy in recurrent...
Autores principales: | Gupta, Sudeep, Nag, Shona, Aggarwal, Shyam, Rauthan, Amit, Warrier, Narayanankutty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827246/ https://www.ncbi.nlm.nih.gov/pubmed/31685032 http://dx.doi.org/10.1186/s13048-019-0579-0 |
Ejemplares similares
-
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review
por: Nag, Shona, et al.
Publicado: (2022) -
Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer
por: Srinivasan, K. N, et al.
Publicado: (2014) -
Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013) -
Current status of maintenance therapy for advanced ovarian cancer
por: Hope, Joanie Mayer, et al.
Publicado: (2010) -
Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives
por: Reverdy, Thibaut, et al.
Publicado: (2020)